𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of VEGF receptors in angiogenesis; complex partnerships

✍ Scribed by S. Cébe-Suarez; A. Zehnder-Fjällman; K. Ballmer-Hofer


Publisher
Springer
Year
2006
Tongue
English
Weight
230 KB
Volume
63
Category
Article
ISSN
1420-682X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


VEGF stimulates PKD-mediated CREB-depend
✍ Dezheng Zhao; Sachin Desai; Huiyan Zeng 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 428 KB

## Abstract New vessel formation is critical for solid tumor growth and it is primarily stimulated by the most potent angiogenic factor vascular endothelial growth factor (VEGF or VEGF‐A165). VEGF promotes endothelial cell proliferation by initiating signaling cascades to increase gene transcriptio

Expression profiling of ETS and MMP fact
✍ Sun-Hee Heo; Young-Jin Choi; Hyun-Mo Ryoo; Je-Yoel Cho 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

## Abstract In the process of angiogenesis, working of many transcription factors at the proper time is important to activate angiogenesis‐related genes such as cytokine, matrix protease and adhesion molecules. In this study, we searched for Ets transcription factors and matrix metalloproteinases (

The role of contestation in NGO partners
✍ Tom Harrison 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract In this article I use a case study of the relationship between an international non‐government development organisation (NGO) and one of its local partner NGOs to question the desirability of basing NGO partnerships on the principle of subsidiarity. I argue that devolving maximum contro

Cholinergic modulation of angiogenesis:
✍ Jenny C.F. Wu; Andrzej Chruscinski; Vinicio A. De Jesus Perez; Harvir Singh; Mar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 615 KB

## Abstract Pathological angiogenesis contributes to tobacco‐related diseases such as malignancy, atherosclerosis and age‐related macular degeneration. Nicotine acts on endothelial nicotinic acetylcholine receptors (nAChRs) to activate endothelial cells and to augment pathological angiogenesis. In